Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alibaba ( (BABA) ) has provided an update.
On July 9, 2025, Alibaba Group announced the completion of a private offering of HK$12.023 billion in Zero Coupon Exchangeable Bonds due 2032. These bonds are linked to Alibaba Health Information Technology Limited shares and are expected to be listed on the Vienna MTF. The bonds, which are unsecured and unsubordinated, allow holders to exchange them for Alibaba Health shares or cash. This move is part of Alibaba’s strategy to maintain Alibaba Health as a flagship healthcare platform and drive transformation in the ‘AI + Healthcare’ industry.
The most recent analyst rating on (BABA) stock is a Buy with a $180.00 price target. To see the full list of analyst forecasts on Alibaba stock, see the BABA Stock Forecast page.
Spark’s Take on BABA Stock
According to Spark, TipRanks’ AI Analyst, BABA is a Outperform.
Alibaba’s strong earnings performance and strategic focus on AI and cloud technology drive the positive outlook, despite technical indicators suggesting potential short-term weakness. The fair valuation and robust financials support a favorable long-term perspective.
To see Spark’s full report on BABA stock, click here.
More about Alibaba
Alibaba Group is a leading company in the e-commerce industry, focusing on building the future infrastructure of commerce. It aims to facilitate business operations globally without prioritizing size or power, aspiring to be a company that lasts for 102 years.
Average Trading Volume: 15,090,940
Technical Sentiment Signal: Hold
Current Market Cap: $256.3B
Find detailed analytics on BABA stock on TipRanks’ Stock Analysis page.